Use of therapeutic drug monitoring in the long-term valaciclovir therapy of relapsing herpes simplex virus encephalitis in children
Open Access
- 14 October 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 64 (6), 1340-1341
- https://doi.org/10.1093/jac/dkp373
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy: Can intravenous acyclovir be substituted by oral valacyclovir?Medical and Pediatric Oncology, 2002
- Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness.Drugs in R&D, 2002
- Exacerbation of Herpes Simplex Encephalitis after Successful Treatment with AcyclovirClinical Infectious Diseases, 2000
- A simple high performance liquid chromatography (HPLC) assay for aciclovir and ganciclovir in serumJournal of Antimicrobial Chemotherapy, 1996
- Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacyAntiviral Research, 1995
- Dosing considerations for oral acyclovir following neonatal herpes diseaseActa Paediatrica, 1994
- Herpes simplex encephalitis with relapse.Archives of Disease in Childhood, 1991
- Overview of acyclovir pharmacokinetic disposition in adults and childrenAmerican Journal Of Medicine, 1982